Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorZURCHER, Kathrin
dc.contributor.authorCOX, Samyra R.
dc.contributor.authorBALLIF, Marie
dc.contributor.authorENANE, Leslie A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMARCY, Olivier
dc.contributor.authorYOTEBIENG, Marcel
dc.contributor.authorREUBENSON, Gary
dc.contributor.authorIMSANGUAN, Worarat
dc.contributor.authorOTERO, Larissa
dc.contributor.authorSURYAVANSHI, Nishi
dc.contributor.authorDUDA, Stephany N.
dc.contributor.authorEGGER, Matthias
dc.contributor.authorTORNHEIM, Jeffrey A.
dc.contributor.authorFENNER, Lukas
dc.date.accessioned2023-03-14T13:35:17Z
dc.date.available2023-03-14T13:35:17Z
dc.date.issued2022-03-01
dc.identifier.issn2767-3375 (Electronic) 2767-3375 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/172297
dc.description.abstractEnTuberculosis (TB) is the leading cause of death among PLHIV and multidrug-resistant-TB (MDR-TB) is associated with high mortality. We examined the management for adult PLHIV coinfected with MDR-TB at ART clinics in lower income countries. Between 2019 and 2020, we conducted a cross-sectional survey at 29 ART clinics in high TB burden countries within the global IeDEA network. We used structured questionnaires to collect clinic-level data on the TB and HIV services and the availability of diagnostic tools and treatment for MDR-TB. Of 29 ART clinics, 25 (86%) were in urban areas and 19 (66%) were tertiary care clinics. Integrated HIV-TB services were reported at 25 (86%) ART clinics for pan-susceptible TB, and 14 (48%) clinics reported full MDR-TB services on-site, i.e. drug susceptibility testing [DST] and MDR-TB treatment. Some form of DST was available on-site at 22 (76%) clinics, while the remainder referred testing off-site. On-site DST for second-line drugs was available at 9 (31%) clinics. MDR-TB treatment was delivered on-site at 15 (52%) clinics, with 10 individualizing treatment based on DST results and five using standardized regimens alone. Bedaquiline was routinely available at 5 (17%) clinics and delamanid at 3 (10%) clinics. Although most ART clinics reported having integrated HIV and TB services, few had fully integrated MDR-TB services. There is a continued need for increased access to diagnostic and treatment options for MDR-TB patients and better integration of MDR-TB services into the HIV care continuum.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.title.enIntegrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries
dc.title.alternativePLOS Glob Public Healthen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1371/journal.pgph.0000180en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed36778080en_US
bordeaux.journalPLOS Global Public Healthen_US
bordeaux.volume2en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamGHiGS_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04028614
hal.version1
hal.date.transferred2023-03-14T13:35:32Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLOS%20Global%20Public%20Health&rft.date=2022-03-01&rft.volume=2&rft.issue=3&rft.eissn=2767-3375%20(Electronic)%202767-3375%20(Linking)&rft.issn=2767-3375%20(Electronic)%202767-3375%20(Linking)&rft.au=ZURCHER,%20Kathrin&COX,%20Samyra%20R.&BALLIF,%20Marie&ENANE,%20Leslie%20A.&MARCY,%20Olivier&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée